Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Anticancer Drugs. 2013 Mar;24(3):10.1097/CAD.0b013e32835d29fd. doi: 10.1097/CAD.0b013e32835d29fd

Figure 5. The effect of CNTO95 and dasatinib on integrin signal transduction in HCT-116 cells (A, B) and RKO cells (C, D).

Figure 5

Western blots of whole cell lysates from drug treated and untreated control HCT-116 cells (A) or RKO cells (C). Quantifications of paxillin phosphorylation in HCT-116 cells (B) and RKO cells (D) are displayed as bar graphs. *, significantly different from either drug treatment, P<0.05. Data are shown as the mean ± SD.